Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JORGE PLUTZKY

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1639135023
CMS profile
119057
Location
BOSTON, MA

General Payments · PY2018–2024

$730,447.97

  • Reported across 286 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$101,751.46

47 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $54,401.17 11
Corcept Therapeutics $14,063.46 13
Boehringer Ingelheim Pharmaceuticals, Inc. $13,235.59 10
Novo Nordisk AS $12,971.24 12
IDORSIA PHARMACEUTICALS US INC $7,080.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $270,684.39 126
PY2019 $160,798.52 48
PY2020 $78,680.80 20
PY2021 $22,241.32 5
PY2022 $40,725.27 14
PY2023 $55,566.21 26
PY2024 $101,751.46 47

Payment records · PY2024 (47)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Boehringer Ingelheim Pharmaceuticals, Inc. $217.45 02/23/2024 Travel and Lodging Undisputed 01/23/2026 1118088744 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $434.54 02/23/2024 Travel and Lodging Undisputed 01/23/2026 1118088746 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $35.00 03/28/2024 Food and Beverage Undisputed 01/23/2026 1118088736 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $140.00 03/28/2024 Travel and Lodging Undisputed 01/23/2026 1118088742 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $11,560.00 03/28/2024 Consulting Fee Undisputed 01/23/2026 1118088750 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $31.98 04/18/2024 Food and Beverage Undisputed 01/23/2026 1118088732 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $31.98 04/18/2024 Food and Beverage Undisputed 01/23/2026 1118088734 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $39.99 04/18/2024 Food and Beverage Undisputed 01/23/2026 1118088738 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $39.99 04/18/2024 Food and Beverage Undisputed 01/23/2026 1118088740 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $704.66 04/18/2024 Travel and Lodging Undisputed 01/23/2026 1118088748 CMS
Corcept Therapeutics $4,350.00 06/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117762279 CMS
Corcept Therapeutics $3.31 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1117762349 CMS
Corcept Therapeutics $51.54 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1117762351 CMS
Corcept Therapeutics $330.71 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1117762353 CMS
Corcept Therapeutics $59.97 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1117762355 CMS
Corcept Therapeutics $50.00 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1117762357 CMS
Corcept Therapeutics $20.00 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1117762359 CMS
Corcept Therapeutics $21.90 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1117762361 CMS
Corcept Therapeutics $62.18 11/15/2024 Food and Beverage Undisputed 01/23/2026 1117762363 CMS
Corcept Therapeutics $42.40 11/15/2024 Food and Beverage Undisputed 01/23/2026 1117762365 CMS
Corcept Therapeutics $161.45 11/15/2024 Food and Beverage Undisputed 01/23/2026 1117762367 CMS
Corcept Therapeutics $3,240.00 12/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117762379 CMS
Corcept Therapeutics $5,670.00 12/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117762347 CMS
IDORSIA PHARMACEUTICALS US INC $7,080.00 09/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1146758418 CMS
Novo Nordisk AS $387.50 04/04/2024 Consulting Fee Undisputed 01/23/2026 1096552213 CMS
Novo Nordisk AS $564.26 04/06/2024 Travel and Lodging Undisputed 01/23/2026 1096552175 CMS
Novo Nordisk AS $4,762.23 04/06/2024 Travel and Lodging Undisputed 01/23/2026 1096553293 CMS
Novo Nordisk AS $137.87 04/06/2024 Travel and Lodging Undisputed 01/23/2026 1096553379 CMS
Novo Nordisk AS $402.51 06/22/2024 Travel and Lodging Undisputed 01/23/2026 1096552725 CMS
Novo Nordisk AS $429.00 06/22/2024 Travel and Lodging Undisputed 01/23/2026 1096552783 CMS
Novo Nordisk AS $2,386.87 11/04/2024 Travel and Lodging Undisputed 01/23/2026 1096552259 CMS
Novo Nordisk AS $1,049.68 11/04/2024 Travel and Lodging Undisputed 01/23/2026 1096552573 CMS
Novo Nordisk AS $837.21 11/04/2024 Travel and Lodging Undisputed 01/23/2026 1096552715 CMS
Novo Nordisk AS $164.11 11/04/2024 Food and Beverage Undisputed 01/23/2026 1096552767 CMS
Novo Nordisk AS $925.00 11/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1096553071 CMS
Novo Nordisk AS $925.00 11/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1096553097 CMS
Novo Nordisk Inc $9,300.00 03/25/2024 Consulting Fee Undisputed 01/23/2026 1096797723 CMS
Novo Nordisk Inc $2,325.00 03/25/2024 Consulting Fee Undisputed 01/23/2026 1097274235 CMS
Novo Nordisk Inc $27,125.00 03/25/2024 Consulting Fee Undisputed 01/23/2026 1097538520 CMS
Novo Nordisk Inc $387.50 11/12/2024 Consulting Fee Undisputed 01/23/2026 1096700180 CMS
Novo Nordisk Inc $1,550.00 11/19/2024 Consulting Fee Undisputed 01/23/2026 1096914754 CMS
Novo Nordisk Inc $11,043.75 11/20/2024 Consulting Fee Undisputed 01/23/2026 1096569864 CMS
Novo Nordisk Inc $144.56 11/20/2024 Food and Beverage Undisputed 01/23/2026 1096804929 CMS
Novo Nordisk Inc $1,058.79 11/20/2024 Travel and Lodging Undisputed 01/23/2026 1097239379 CMS
Novo Nordisk Inc $333.07 11/20/2024 Travel and Lodging Undisputed 01/23/2026 1097301077 CMS
Novo Nordisk Inc $358.50 11/20/2024 Travel and Lodging Undisputed 01/23/2026 1097661913 CMS
Novo Nordisk Inc $775.00 11/26/2024 Consulting Fee Undisputed 01/23/2026 1097495309 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.